Infections Due to Mixed Anaerobic Organisms¶
Chapter 182 | Part 5: Infectious Diseases
KEY CLINICAL POINTS¶
- Anaerobic bacteria are critical components of the human microbiota, particularly in mucosal surfaces, and are often involved in polymicrobial infections.
- Anaerobic infections require an anaerobic environment and are often associated with abscesses, gas formation, and mixed microbial etiology.
- Common pathogens include Bacteroides fragilis, Prevotella, Fusobacterium, and Peptostreptococcus species, with B. fragilis being the most frequently isolated anaerobe in intraabdominal infections.
- Diagnosis requires proper specimen collection, anaerobic transport, and culture techniques due to the challenges in isolating anaerobes.
- Antibiotic therapy must cover both aerobic and anaerobic organisms, with metronidazole, β -lactam/ β -lactamase inhibitors, and carbapenems as first-line agents.
1. DEFINITION & OVERVIEW¶
Anaerobic bacteria are organisms that grow in the absence of oxygen. They are divided into obligate anaerobes (killed by oxygen), aerotolerant organisms (tolerate oxygen but do not use it), and facultative anaerobes (grow with or without oxygen). Anaerobes are part of the normal microbiota in mucosal surfaces and are involved in polymicrobial infections when mucosal barriers are breached.
Table 182-1 The Anaerobic Human Microbiota: An Overview¶
| ANATOMIC SITE | TOTAL BACTERIAa | ANAEROBIC/AEROBIC RATIO | POTENTIAL PATHOGEN(S) |
|---|---|---|---|
| Nose | 103–104 | 2:1 | Peptostreptococcus spp., Prevotella spp. |
| Oral cavity | 108–109 | 10:1 | Fusobacterium nucleatum, Prevotella spp. |
| Tooth surface | 1010–1011 | 1:1 | Prevotella melaninogenica, Prevotella oralis group |
| Gingival crevices | 1011–1012 | 103:1 | Bacteroides ureolyticus group, Peptostreptococcus spp. |
| Stomach | 100–103 | 1:10 | Lactobacillus spp. |
| Duodenum | 101–105 | 1:1 | Lactobacillus spp., Streptococcus spp. |
| ANATOMIC SITE | TOTAL BACTERIAa | ANAEROBIC/AEROBIC RATIO | POTENTIAL PATHOGEN(S) |
|---|---|---|---|
| Jejunum | 103–106 | 1:1 | Streptococcus spp., Lactobacillus spp., Peptostreptococcus spp. |
| Ileum | 104–109 | 10:1 | Bacteroides spp., Streptococcus spp., Enterococcus spp. |
| Cecum and colon | 1011–1012 | 103:1 | Bacteroides spp. (principally members of the B. fragilis group), Prevotella spp., Clostridium spp. |
| Female genital tract | 107–109 | 10:1 | Peptostreptococcus spp., Bacteroides spp., Prevotella spp. |
| Skin | 104–106 | 100:1 | Cutibacterium acnes |
1.1 Anaerobic Microbiota Distribution¶
Anaerobes dominate in the oral cavity, gastrointestinal tract, and female genital tract. The oral cavity has a 10:1 ratio of anaerobes to aerobes, while the colon has a 1000:1 ratio. The gut microbiota includes Bacteroidetes and Firmicutes phyla, with Bacteroides and Prevotella species being predominant.
1.2 Pathogenesis¶
Anaerobic infections occur in anaerobic environments created by tissue ischemia, trauma, or mucosal disruption. Facultative organisms maintain reduced oxidation-reduction potential, allowing obligate anaerobes to proliferate. Virulence factors include adherence, toxin production, and synergistic interactions with other microbes.
2. EPIDEMIOLOGY¶
Anaerobic infections are common in hospitalized patients, with anaerobes accounting for 7–8% of inpatient and 13–15% of outpatient isolates. They are frequently associated with intraabdominal infections, soft tissue infections, and head and neck infections. Bacteremia from anaerobes is often polymicrobial and has a high mortality rate.
2.1 Risk Factors¶
Mucosal disruption, trauma, surgery, and immunocompromise increase risk. Common sites include the oral cavity, gastrointestinal tract, and female genital tract. Anaerobes are implicated in 30–50% of intraabdominal infections.
2.2 Demographics¶
Infections are more common in older adults and immunocompromised patients. Lemierre’s syndrome (Fusobacterium necrophorum) is more prevalent in young adults. Neonatal noma occurs in malnourished children.
3. ETIOLOGY & PATHOPHYSIOLOGY¶
Anaerobic infections are polymicrobial, involving synergistic interactions between obligate anaerobes and facultative organisms. Key pathogens include Bacteroides fragilis, Prevotella, Fusobacterium, and Peptostreptococcus. Virulence factors include capsular polysaccharides, endotoxins, and adherence mechanisms.
3.1 Pathogenic Mechanisms¶
Anaerobes produce exotoxins (e.g., botulinum toxin), endotoxins (lipid A), and enzymes (e.g., collagenase). Capsular polysaccharides (e.g., B. fragilis PSA) mediate abscess formation and immune evasion.
3.2 Immune Evasion¶
Anaerobes modulate host immunity via polysaccharides (e.g., B. fragilis PSA) and endotoxins. They inhibit phagocytosis and promote inflammation through cytokine release.
4. CLINICAL FEATURES¶
Clinical manifestations include abscess formation, foul-smelling purulence, gas formation, and systemic symptoms. Common sites include the abdomen, head and neck, and female genital tract. Complications include septicemia, meningitis, and septic arthritis.
4.1 Common Presentations¶
Abscesses, necrotizing fasciitis, and gas gangrene are typical. Foul-smelling discharge, subcutaneous gas, and localized pain are common signs. Systemic symptoms include fever and leukocytosis.
4.2 Complications¶
Lemierre’s syndrome (F. necrophorum), septic arthritis, and abscess-related sepsis. Anaerobic infections can lead to respiratory failure, septic shock, and multiorgan failure.
5. DIFFERENTIAL DIAGNOSIS¶
Differential diagnoses include aerobic infections, chemical pneumonitis, and fungal infections. Key distinguishing features include anaerobic culture results, foul-smelling discharge, and abscess formation.
5.1 Key Differentiators¶
Anaerobic infections often present with abscesses, gas, and polymicrobial flora. Foul-smelling discharge and localized pain are more common than in aerobic infections. Culture results are critical for differentiation.
6. INVESTIGATIONS & DIAGNOSIS¶
Diagnosis requires proper specimen collection, anaerobic transport, and culture. Imaging (CT, MRI) and Gram stain are essential. Culture-independent methods (e.g., 16S rDNA sequencing) identify uncultivable species.
Table 182-2 Antimicrobial Therapy That Is Typically Active against Commonly Encountered Anaerobes¶
| ANTIBIOTIC(S) | CAVEATS |
|---|---|
| Metronidazole | Clinically unreliable against gram-positive non-spore-forming anaerobes (e.g., Actinomyces spp., Propionibacterium spp., Peptostreptococcus spp.). |
| ANTIBIOTIC(S) | CAVEATS |
|---|---|
| b-Lactam/b-lactamase inhibitor combinations (ampicillin-sulbactam, piperacillin-tazobactam) | Limited anaerobic activity; resistance increasing in Bacteroides species. |
| Clindamycin | Resistance rates increasing in Bacteroides species (up to 33% in the U.S.). |
| Carbapenems (meropenem, imipenem) | Low resistance (<5%); effective against Bacteroides and Clostridium species. |
| Chloramphenicol | Historically effective but resistance noted in some isolates. |
6.1 Specimen Collection¶
Specimens from sterile sites (blood, CSF) and non-sterile sites (abscess, wound) should be collected. Avoid contamination by normal flora. Use anaerobic transport media for specimens from the oral cavity, vagina, or gut.
6.2 Diagnostic Criteria¶
Positive anaerobic cultures, presence of abscesses, and clinical context (e.g., trauma, surgery). Gram stain may show mixed flora with anaerobic organisms.
7. MANAGEMENT & TREATMENT¶
Treatment includes antibiotics, surgical drainage, and debridement. Empirical therapy must cover aerobic and anaerobic organisms. Antibiotic selection depends on infection site and local resistance patterns.
7.1 Antibiotic Therapy¶
First-line agents: metronidazole, β -lactam/ β -lactamase inhibitors (e.g., piperacillin-tazobactam), and carbapenems. Avoid aminoglycosides and trimethoprim-sulfamethoxazole for anaerobic coverage.
7.2 Surgical Intervention¶
Drainage of abscesses, debridement of necrotic tissue, and removal of foreign bodies. Surgical intervention is critical for intraabdominal and head/neck infections.
8. PROGNOSIS & COMPLICATIONS¶
Mortality rates vary by infection site and patient age. Anaerobic bacteremia has a 60% mortality rate if untreated. Complications include septic shock, multiorgan failure, and chronic infections (e.g., actinomycosis).
8.1 Mortality Factors¶
Age >60 years, multiple organism infections, and failure to surgically address the source. Bacteroides fragilis bacteremia has a 60% mortality rate without treatment.
8.2 Long-Term Outcomes¶
Chronic infections (e.g., actinomycosis, osteomyelitis) may require prolonged antibiotic therapy. Recurrence is common without complete surgical debridement.
9. SPECIAL CONSIDERATIONS¶
Pregnancy, pediatric, and elderly patients require tailored antibiotic regimens. Anaerobic infections in pregnancy may complicate obstetric outcomes. Neonatal noma is a severe condition in malnourished children.
9.1 Pregnancy¶
Anaerobic infections in pregnancy may require broad-spectrum antibiotics. Avoid drugs with teratogenic potential (e.g., tetracyclines).
9.2 Pediatrics¶
Noma and Lemierre’s syndrome are more common in children. Early surgical intervention is critical for abscesses and septic arthritis.
10. KEY POINTS & CLINICAL PEARLS¶
- Anaerobic infections are polymicrobial and often require broad-spectrum antibiotics. 2. Proper specimen collection and anaerobic culture are essential for diagnosis. 3. Bacteroides fragilis is the most common anaerobic pathogen in intraabdominal infections. 4. Metronidazole and carbapenems are first-line agents for anaerobic coverage. 5. Surgical drainage is critical for abscesses and necrotizing infections.